ArticleClinical and molecular hepatology2024

Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide.

Hyeyeon Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.